NEW DELHI: Make in India logote melai kena thaka ‘Meril Life Sciences’ Saturday te tai laga first indigenously design aro manufacture kora artificial aortic valve patients karne banaishe. Etu artificial aortic valve toh open heart valve replacement surgery koribole mon nathaka high risk patients khan karne banaishe.
Transcatheter Aortic Heart Valve Replacement (TAVR) toh brand naam “Myval” under te sell kuribo. TAVR toh minimally invasive procedure ase. Etu procedure te doctor para artificial valve toh patient laga bimar huwa valve te rakhide.
Etu bimar huwa valve ke replace koribole dusra tarika(another way) ase. Etu toh open heart surgery koribo mon nathaka patients khan karne ase.
Sanjeev Bhatt, Vice President Corporate Strategy, Meril Life Sciences koishe Meril etu therapy ke desh te commercially available kora laga first Indian company ase. Etu technology laga commercialisation para joldi Meril next generation laga treatment para bishi hazar patients(desh aro duniya) te bhal anibo.
TAVR toh US-based medical device makers Medtronics and Edwards Lifesciences para dominate kori kena thakishe.
Mr. Bhatt koishe healthcare mon te rakhi kena , etu technology toh bishi dam nohubo.
Company toh TAVR commercialisation karne Indian drug regulator Central Drugs Standard Control Organisation (CDSCO) para approval paishe.
Bhatt koishe etu approval toh India te huwa clinical trial laga successful result para paishe. Etu trial toh 14 hospitals te hoishe.
Ravinder Singh Rao, Eternal laga Interventional Cardiologist hesab te Myval laga first patient toh 1.5 years complete kurishe. Etu patient toh symptom-free aro bhal life thaki ase. Etu valve toh effective ase. Etu valve para patient ke aortic stenosis para mura aro hospitalization hubo para relieve kurishe.
Rao koishe “Myval TAVR technology toh joldi aortic stenosis para duk pai thaka bishi million patients karne boon hubo le ase”.
Add Comment